$BOMO
bowmo, Inc.

2024 Q3 Form 10-Q Financial Statement

#000121390024100027 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $62.00K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $62.00K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $309.9K
YoY Change -13.76%
% of Gross Profit 499.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $206.3K $309.9K
YoY Change -33.43% -13.76%
Operating Profit -$206.3K -$247.9K
YoY Change -16.78% -31.01%
Interest Expense $169.4K
YoY Change -15.43%
% of Operating Profit
Other Income/Expense, Net $41.65K -$749.6K
YoY Change -105.56% 274.28%
Pretax Income -$164.6K -$997.4K
YoY Change -83.49% 78.25%
Income Tax
% Of Pretax Income
Net Earnings -$164.6K -$997.4K
YoY Change -83.49% 78.25%
Net Earnings / Revenue -1608.77%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 33.36B shares
Diluted Shares Outstanding 33.30M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.870K
YoY Change -95.93%
Cash & Equivalents $5.345K $3.868K
Short-Term Investments
Other Short-Term Assets $860.00
YoY Change
Inventory
Prepaid Expenses
Receivables $18.17K
Other Receivables $0.00
Total Short-Term Assets $23.52K $4.727K
YoY Change 397.5% -95.03%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.618K $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $23.52K $4.727K
Total Long-Term Assets $2.618K $0.00
Total Assets $26.14K $4.727K
YoY Change 452.89% -95.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.235M $952.8K
YoY Change 29.62% 128.36%
Accrued Expenses $13.50K $364.6K
YoY Change -96.3% -51.64%
Deferred Revenue
YoY Change
Short-Term Debt $896.4K
YoY Change 147.41%
Long-Term Debt Due $446.7K
YoY Change 73.69%
Total Short-Term Liabilities $4.730M $6.854M
YoY Change -30.99% 132.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.730M $6.854M
Total Long-Term Liabilities $0.00
Total Liabilities $4.924M $6.854M
YoY Change -28.17% 110.18%
SHAREHOLDERS EQUITY
Retained Earnings -$13.85M -$12.25M
YoY Change 13.01% 119.84%
Common Stock $1.365K $333.6K
YoY Change -99.59% 52.78%
Preferred Stock
YoY Change
Treasury Stock (at cost) $773.5K $773.5K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$4.898M -$6.850M
YoY Change
Total Liabilities & Shareholders Equity $26.14K $4.727K
YoY Change 452.89% -95.03%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$164.6K -$997.4K
YoY Change -83.49% 78.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$46.58K
YoY Change -83.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.30K
YoY Change -128.0%
NET CHANGE
Cash From Operating Activities -46.58K
Cash From Investing Activities 0.000
Cash From Financing Activities -27.30K
Net Change In Cash -73.88K
YoY Change -61.06%
FREE CASH FLOW
Cash From Operating Activities -$46.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NONE
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1365 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
535 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9471986 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8876064 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136458010 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33300997 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136458010 shares
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Gross Profit
GrossProfit
usd
bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
usd
bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
usd
bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54624
dei Entity Registrant Name
EntityRegistrantName
Bowmo, inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4144571
dei Entity Address Address Line1
EntityAddressAddressLine1
99 Wall Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 891
dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10005
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
398-0002
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
BOMO
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
136458010 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5345 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6308 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18172 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18172 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1838 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
23517 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
26318 usd
CY2024Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
858 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2618 usd
CY2024Q3 us-gaap Assets
Assets
26135 usd
CY2023Q4 us-gaap Assets
Assets
26318 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1235030 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1144735 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13500 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213707 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
364598 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
364598 usd
CY2024Q3 bomo Accrued Officer Compensation Current
AccruedOfficerCompensationCurrent
1658583 usd
CY2023Q4 bomo Accrued Officer Compensation Current
AccruedOfficerCompensationCurrent
1384499 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
91127 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
98193 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
440109 usd
CY2024Q3 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
205684 usd
CY2023Q4 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
205684 usd
CY2024Q3 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
200000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
564237 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433818 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4730452 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4471650 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
193202 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
193202 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4923654 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4664852 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53520830 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53520830 shares
CY2024Q3 bomo Treasury Stock Share
TreasuryStockShare
2917 shares
CY2023Q4 bomo Treasury Stock Share
TreasuryStockShare
2917 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13848604 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12992877 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4897519 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4638534 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26135 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26318 usd
CY2023Q3 us-gaap Revenues
Revenues
62000 usd
us-gaap Revenues
Revenues
66476 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
62000 usd
us-gaap Gross Profit
GrossProfit
66476 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
209303 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
375000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
431421 usd
CY2023Q3 bomo Consulting Fees
ConsultingFees
30000 usd
bomo Consulting Fees
ConsultingFees
90000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
49750 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
3415 usd
us-gaap Professional Fees
ProfessionalFees
114750 usd
us-gaap Professional Fees
ProfessionalFees
166884 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31537 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67163 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93143 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
174584 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
206287 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
309881 usd
us-gaap Operating Expenses
OperatingExpenses
582893 usd
us-gaap Operating Expenses
OperatingExpenses
862889 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-206287 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-247881 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-582893 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-796413 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
169369 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
666774 usd
bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
32429 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41646 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-580189 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-272834 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-149909 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41646 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-749558 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-272834 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-849112 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-164641 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-997439 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-855727 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1645525 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-164641 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-997439 usd
us-gaap Net Income Loss
NetIncomeLoss
-855727 usd
us-gaap Net Income Loss
NetIncomeLoss
-1645525 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33300997 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31260512 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31260512 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5896662 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
85885 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
24989 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
581691 usd
us-gaap Net Income Loss
NetIncomeLoss
-1645525 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6849621 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4638534 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
369286 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
227455 usd
us-gaap Net Income Loss
NetIncomeLoss
-855727 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4897519 usd
us-gaap Profit Loss
ProfitLoss
-855727 usd
us-gaap Profit Loss
ProfitLoss
-1645525 usd
bomo Interest Expense Incurred On Put Premium On Stock Settled Debt
InterestExpenseIncurredOnPutPremiumOnStockSettledDebt
111000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-98319 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
418163 usd
us-gaap Share Based Compensation
ShareBasedCompensation
265802 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23905 usd
bomo Initial Derivative Expense
InitialDerivativeExpense
-32429 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
272834 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
149910 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15541 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-980 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1760 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-52129 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
139454 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-200207 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-286 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
30511 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
274083 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
324139 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
91127 usd
bomo Increase Decrease In Acquisitionpayable
IncreaseDecreaseInAcquisitionpayable
200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-369118 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-134957 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
89000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
596751 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
243596 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
117278 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
368155 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28278 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-963 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-163235 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6308 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167103 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5345 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3868 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
369286 usd
bomo Derivative Liability Adjustments To Additional Paid In Capital
DerivativeLiabilityAdjustmentsToAdditionalPaidInCapital
227455 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">NOTE 1 – BACKGROUND</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Reverse Merger and Corporate Restructure</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 4, 2022, Cruzani, Inc. (“Cruzani” or the “Predecessor”) entered into a merger agreement (the “Merger Agreement”) with Bowmo, Inc. (“Bowmo”) and Bowmo Merger Sub, Inc. to acquire Bowmo. (the “Acquisition”). The transactions contemplated by the Merger Agreement were consummated on May 4, 2022, and pursuant to the terms of the Merger Agreement, all outstanding shares of Bowmo were exchanged for shares of Cruzani’s common stock and Bowmo became Cruzani’s wholly owned subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The merger was effected pursuant to the Merger Agreement. The merger is being accounted for as a reverse merger whereby Bowmo is the acquirer for accounting purposes. Bowmo is considered the acquiring company for accounting purposes as upon completion of the Merger, Bowmo’s former stockholders held a majority of the voting interest of the combined company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the merger, the Company issued Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders. Upon completion of the acquisition, Bowmo is treated as the surviving entity and accounting acquirer although Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Accounting for Reverse Merger</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of Cruzani assets acquired and liabilities assumed was based upon management’s estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the allocation of purchase price of the acquisition: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid">Tangible Assets Acquired:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Allocation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">517</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(326,400</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,197,027</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued officer compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(453,333</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(620,933</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Put premium on stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(230,743</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loans payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(254,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Tangible Assets Acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,082,419</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Equity Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33,815</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series E Preferred stock to be issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(166,331</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Common stock 20,000,000,000 shares authorized, $0.00001 par value; 8,955,014,498 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(89,550</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Treasury stock, at cost – 2,917 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">773,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,648,676</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic">Consideration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Organization and Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bowmo, Inc. (FKA Cruzani, Inc.) (the “Company”) is an AI-powered recruiting platform. The Company’s principal lines of business are direct placement of candidates with employers and Recruiting as a Service which allows the Company’s customers to outsource the management of their recruiting process to the Company. The Company offers recruiting software and services through an online AI-driven platform to connect potential candidates to employers for all businesses looking to address hiring needs. The Company was incorporated as a Delaware corporation in 2016.</p>
us-gaap Net Income Loss
NetIncomeLoss
-855727 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-582893 usd
CY2024Q3 bomo Working Capital Deficit
WorkingCapitalDeficit
4706935 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13848604 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5345 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6308 usd
us-gaap Revenues
Revenues
66476 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentrations of credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents, and accounts receivable. Cash and cash equivalents are held in United States financial institutions. At times such amounts may exceed federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p>
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
58092 usd
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
198982 usd
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
216367 usd
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4595717 usd
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-287779 usd
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.02
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Loans Payable
LoansPayable
269500 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
254500 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
6807 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7066 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7336 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7616 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
240675 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
269500 usd
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
403083 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
646679 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
304889 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
206570 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
98194 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
440109 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q3 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.12 pure
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
6728 usd
CY2023 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
0 usd
CY2022 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
27856 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
110992 usd
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
-2718645 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
-112537 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-544850 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2172250 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
4035300 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
651156 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
1645712 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433818 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
130419 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
564237 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9693 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
38771 usd
CY2019Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
10000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
18094721962 usd
CY2023 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
6364768689 usd
CY2024Q3 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
0 usd
bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
82937180 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136458010 shares
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.025
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.001
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
77800000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y2M8D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
bomo Increased Decrease Indebtedness
IncreasedDecreaseIndebtedness
1200000 usd
CY2017Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
27084 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12992877 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9243925 usd
bomo Percentage Of Annual Utilization Of Current Year Income Percentage
PercentageOfAnnualUtilizationOfCurrentYearIncomePercentage
0.80 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3361000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2923000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
517618 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
245000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
192697 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
193000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4071315 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3361000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4071315 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3361000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1529 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1529 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.025 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.025 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3879 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3879 pure
bomo Percentage Of Minimum Change In Ownership
PercentageOfMinimumChangeInOwnership
0.50 pure
CY2020Q1 bomo Coronavirus Aid Relief And Economic Security Act Relief Package Amount
CoronavirusAidReliefAndEconomicSecurityActReliefPackageAmount
2000000000000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
710315 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1777000 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
usd
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
usd
CY2024Q3 bomo Consulting Fees
ConsultingFees
usd
bomo Consulting Fees
ConsultingFees
usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2024Q3 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
usd
CY2023Q3 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
usd
CY2024Q3 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2023Q3 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
shares
bomo Interest Expense Incurred On Put Premium On Stock Settled Debt
InterestExpenseIncurredOnPutPremiumOnStockSettledDebt
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
bomo Initial Derivative Expense
InitialDerivativeExpense
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
bomo Increase Decrease In Acquisitionpayable
IncreaseDecreaseInAcquisitionpayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
bomo Derivative Liability Adjustments To Additional Paid In Capital
DerivativeLiabilityAdjustmentsToAdditionalPaidInCapital
usd
us-gaap Revenues
Revenues
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001381871

Files In Submission

Name View Source Status
0001213900-24-100027-index-headers.html Edgar Link pending
0001213900-24-100027-index.html Edgar Link pending
0001213900-24-100027.txt Edgar Link pending
0001213900-24-100027-xbrl.zip Edgar Link pending
bomo-20240930.xsd Edgar Link pending
ea0221573-10q_bowmoinc.htm Edgar Link pending
ea022157301ex31-1_bowmoinc.htm Edgar Link pending
ea022157301ex32-1_bowmoinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ea0221573-10q_bowmoinc_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bomo-20240930_cal.xml Edgar Link unprocessable
bomo-20240930_lab.xml Edgar Link unprocessable
bomo-20240930_def.xml Edgar Link unprocessable
bomo-20240930_pre.xml Edgar Link unprocessable